Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/1995
11/16/1995WO1995030673A1 Anti-cancer compounds containing cyclopentaquinazoline ring
11/16/1995CA2189452A1 Methods of in vivo gene delivery
11/16/1995CA2189340A1 Modulators of cytokines of the tgf-.beta. superfamily and methods for assaying for same
11/16/1995CA2158977A1 Retroviral vectors having a reduced recombination rate
11/15/1995EP0682040A1 Humanized immunoglobulins and their production and use
11/15/1995EP0682039A1 CTLA4 molecules and IL4-binding molecules and uses thereof
11/15/1995EP0682027A1 Pyrrolopyrimidine derivatives with antiproliferative action
11/15/1995EP0682026A1 "Stable crystalline (6S)- and (6R)-tetrahydrofolic acid"
11/15/1995EP0681840A1 Use of phosphate diester for the treatment of retinal diseases
11/15/1995EP0681833A2 Nasally administrable compositions
11/15/1995EP0681788A2 Dioxabicyclo[3.3.0] octane derivatives, e.g. sesamin etc., for prevention or alleviation of allergy symptoms
11/15/1995EP0681589A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
11/15/1995EP0681576A1 Oxime derivatives
11/15/1995EP0681470A1 Recombinant living subunit vaccine composition and process for its preparation.
11/15/1995EP0444186B1 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells
11/15/1995EP0238545B1 C20 through c26 amino steroids
11/15/1995CN1030251C Substituted 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives
11/14/1995US5466826 Process for preparing a physical form of pharmaceutical agent
11/14/1995US5466697 8-phenyl-1,6-naphthyridin-5-ones
11/14/1995US5466690 Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity
11/14/1995US5466675 Immunological activity of rhamnolipids
11/14/1995US5466669 Immunostimulatory agent
11/14/1995CA2045481C Immunosupressing agent and process of producing the same
11/11/1995CA2147587A1 Method and composition for prophylaxis and treatment of retinal diseases
11/10/1995WO1996005848A1 A food additive for improving immunity
11/10/1995CA2166285A1 A food additive for improving immunity
11/09/1995WO1995030016A1 Methods for peptide synthesis and purification
11/09/1995WO1995030007A1 Thymidine kinase mutants
11/09/1995WO1995030004A1 Monoclonal antibodies which promote central nervous system remyelination
11/09/1995WO1995029932A1 Process for the preparation of 4-amino-δ4-3-ketosteroids via 4-nitro-δ4-3-ketosteroids
11/09/1995WO1995029697A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995WO1995029682A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWIS?a¿
11/09/1995WO1995029673A1 Methods for modulating t cell responses by manipulating intracellular signal transduction
11/09/1995CA2690298A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995CA2189543A1 Thymidine kinase mutants
11/09/1995CA2189013A1 Binding of e-selectin, p-selectin or l-selectin to sialyl-lewisx or sialyl-lewisa
11/09/1995CA2188760A1 Process for the preparation of 4-amino-3-ketosteroids via 4-nitro-4-3-ketosteroids
11/09/1995CA2165413A1 Methods for peptide synthesis and purification
11/08/1995EP0680513A1 Lysosomal targeting of immunogens
11/08/1995EP0680489A1 Foldback triplex-forming oligonucleotides
11/08/1995EP0680488A1 2,6-diaminopurine derivatives
11/08/1995EP0680336A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants
11/08/1995EP0680331A1 Recombinant virus immunotherapy
11/08/1995EP0680315A1 Method for preparing a viral aerosol
11/08/1995EP0512109B1 Oral pharmaceutical composition containing cyclosporin and process for preparing same
11/08/1995EP0393051B1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES
11/07/1995US5464939 Highly purified protein, production and use thereof
11/07/1995US5464872 Sleep disorders
11/07/1995US5464858 Hypotensive
11/07/1995US5464849 N-hydroxyurea derivatives as antiallergy and antiinflammatory agents
11/07/1995US5464841 Use of delta opioid receptor antagonists to treat immunoregulatory disorders
11/07/1995US5464840 Tricyclic derivatives, compositions and methods of use
11/07/1995US5464838 Aminocarboxylic acid derivatives having antiallergic/antiasthmatic effect and a process for their preparation
11/07/1995US5464822 Polypeptides and polypeptide analogues
11/07/1995US5464819 Physiologically active peptide having immunoregulatory activities
11/07/1995US5464816 Autoimmune disease treatment with nonapeptides
11/07/1995US5464615 Use of transglutaminases as immunosuppressants
11/07/1995US5464614 Stabilized superoxide dismutase (SOD) composition
11/07/1995CA2063872C Pharmaceutical preparation based on plasma proteins
11/04/1995CA2148324A1 Pyrrolopyrimidine derivatives having pharmacological activity
11/02/1995WO1995029239A2 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995WO1995029236A2 Lymphocyte activation antigens and antibodies thereto
11/02/1995WO1995029194A1 Peptides as therapeutic agents for the treatment of auto-immune diseases
11/02/1995WO1995029193A2 Melanoma antigens
11/02/1995WO1995029190A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995WO1995029176A1 Substituted 1,3-oxathiolanes with antiviral properties
11/02/1995WO1995029164A1 Novel sulfur-containing amino acid derivative
11/02/1995WO1995028957A2 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995WO1995028931A1 Spiro-substituted azacycles as neurokinin-3 antagonists
11/02/1995EP0679717A2 Soluble interferon -receptor, its preparation and use
11/02/1995EP0679403A1 Preventive and remedy for allergic disease
11/02/1995EP0679182A1 Delivery of gene products via mesangial cells
11/02/1995EP0679160A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/02/1995EP0679092A1 Cytokine restraining agents
11/02/1995EP0551401B1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
11/02/1995DE4413938A1 Peptide als Therapeutikum für Autoimmunerkrankungen Peptides as therapeutics for autoimmune diseases
11/02/1995CA2188672A1 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995CA2188543A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995CA2188470A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995CA2188031A1 Spiro-substituted azacycles as neurokinin-3 antagonists
10/1995
10/31/1995US5463087 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments
10/31/1995US5463083 2,5-diaryl tetrahydrothiophenes, tetrahydrofurans and 1,3-diaryl-cyclopentanes which act as platelet activating factor receptor antagonists and/or inhibitors of the enzyme 5-lipoxygenase
10/31/1995US5463074 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
10/31/1995US5463063 Preparation of thalidomide; inhibitor of tumor necrosis factor
10/31/1995US5463048 Rapamycin amidino carbamates
10/31/1995US5462939 Treating infectious diseases, septic shock, respiratory diseases, inflammatory conditions, autoimmune diseases, bone diseases
10/31/1995US5462925 Transforming growth factor β2,3
10/31/1995US5462871 Nonapeptides bind to human leukocyte antigens on cell surfaces leading to lysis by cytolytic T lymphocytes
10/29/1995CA2147925A1 Pseudopeptides derived from neurokinins; process for preparing the same and pharmaceutical compositions containing them
10/26/1995WO1995028480A1 Methods of use of uncoated gel particles
10/26/1995WO1995028479A1 Process for producing dendritic cells, cells thus produced and container for carrying out this process
10/26/1995WO1995028424A1 Pharmaceutical peptide formulations for treatment of dust mite allergy
10/26/1995WO1995028422A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995WO1995028406A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
10/26/1995WO1995028398A1 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine
10/26/1995WO1995028386A1 Substituted pyridine leukotriene b4 antagonists
10/26/1995WO1995028178A1 Use of g-csf to reduce acute rejection
10/26/1995WO1995028175A1 Viral ribonucleocapsid as an immunological enhancer
10/26/1995WO1995028170A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995WO1995022537A3 4-amino derivatives of 5-substituted mycophenolic acid
1 ... 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 ... 1172